Aspira Pathlab & Diagnostics Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Share holding
• Capital structures
• Ratio

Mar ' 25	Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21

Profit before tax

2.07

-2.67

-0.09

4.46

1.38

Net cashflow-operating activity

1.88

1.05

-0.01

2.03

5.67

Net cash used in investing activity

0.07

0.14

0.16

-0.51

-0.09

Netcash used in fin. activity

-0.99

-0.95

-0.94

-1.35

-2.17

Net inc/dec in cash and equivlnt

0.95

0.24

-0.79

0.17

3.41

Cash and equivalnt begin of year

0.80

0.57

1.35

1.19

-2.22

Cash and equivalnt end of year

1.75

0.80

0.57

1.35

1.19